{ "run": { "id": "cmnr14dtz04pep6588kf4ysob", "region": "US", "assetId": "cmnr14dtg04pap658x6hufyur", "ticker": "KMB", "snapshotId": "cmnr14dtp04pcp658aqb8cjpr", "promptTemplateId": "cmnqt07si0005lm3jzpxuu1ux", "createdAt": "2026-04-09T05:21:14.755Z", "promptTemplate": { "id": "cmnqt07si0005lm3jzpxuu1ux", "name": "Oficial 08.apr.2026", "version": 1 }, "snapshot": { "id": "cmnr14dtp04pcp658aqb8cjpr", "assetId": "cmnr14dtg04pap658x6hufyur", "asOf": "2026-04-08T20:00:03.000Z", "snapshot": { "asOf": "2026-04-08T20:00:03.000Z", "quote": { "asOf": "2026-04-08T20:00:03.000Z", "open": null, "price": 97, "dayLow": 94.553, "volume": 7200255, "dayHigh": 97.075, "currency": "USD", "prevClose": 93.05, "week52Low": 94.54, "week52High": 144.31 }, "fundamentals": { "pe": 23.2777777777778, "beta": 0.456762436388033, "epsTTM": 5.22, "fcfTTM": 2761000000, "growth": { "epsYoy": -0.1965699208443272, "revenueYoy": -0.1800279190347991 }, "sector": "Converted Paper & Paperboard Prods (No Contaners/Boxes)", "margins": { "net": 0.122879552501976, "gross": 0.360126466832857, "operating": 0.1429440019456436 }, "website": "https://www.kimberly-clark.com/en-us/", "industry": "Consumer goods", "pegRatio": -2.61532679738562, "ebitdaTTM": 3458000000, "forwardPe": 18.7515432098765, "marketCap": 42800000000, "totalCash": 688000000, "totalDebt": 7168000000, "debtEquity": 8.72568306010929, "quickRatio": 0.3621052631578948, "revenueTTM": 16447000000, "companyName": "KIMBERLY CLARK CORP", "priceToBook": 4.70334341698178, "currentRatio": 0.7452631578947368, "dividendYield": 0.0386882274111548, "returnOnAssets": 0.1182009591765119, "returnOnEquity": 1.92786885245902, "analystOpinions": null, "businessSummary": "Kimberly-Clark Corporation is an American multinational consumer goods and personal care corporation that produces mostly paper-based consumer products. The company manufactures sanitary paper products and surgical & medical instruments. Kimberly-Clark brand name products include Kleenex facial tissue, Kotex feminine hygiene products, Cottonelle, Scott and Andrex toilet paper, Wypall utility wipes, KimWipes scientific cleaning wipes and Huggies disposable diapers and baby wipes.", "enterpriseValue": 47937078000, "analystTargetLow": null, "analystTargetHigh": null, "analystTargetMean": null, "fullTimeEmployees": 38000, "sharesOutstanding": 331922371, "enterpriseToEbitda": 13.86265991902834, "analystTargetMedian": null, "enterpriseToRevenue": 2.91463963032772, "operatingCashflowTTM": 2777000000, "analystRecommendationKey": null } }, "createdAt": "2026-04-09T05:21:14.749Z" }, "results": [ { "id": "cmnr14du204pgp658mk3ie8s3", "runId": "cmnr14dtz04pep6588kf4ysob", "modelId": "anthropic", "status": "SUCCESS", "rawOutput": "{\"model\":\"ai-equity-research-v1\",\"as_of\":\"2026-04-08T20:00:03.000Z\",\"ticker\":\"KMB\",\"currency\":\"USD\",\"current_price\":97,\"target_price_6m\":104,\"target_price_12m\":112,\"recommendation\":\"BUY\",\"confidence\":0.6,\"thesis_bullets\":[\"Stock trades near 52-week low with 33% drawdown from highs\",\"Forward PE of 18.8x implies market pricing partial earnings recovery\",\"Strong FCF yield of ~6.4% supports valuation floor and dividend\",\"Revenue and EPS declined ~18-20% YoY likely from divestitures or restructuring\",\"Defensive low-beta consumer staples name with 3.9% dividend yield\"],\"key_drivers\":[{\"driver\":\"Revenue stabilization post-restructuring\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"FCF generation supporting dividend and deleveraging\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Input cost deflation benefiting gross margins\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Elevated leverage with D/E of 8.7x\",\"impact\":\"HIGH\",\"direction\":\"NEG\"},{\"driver\":\"Weak liquidity ratios (current ratio 0.75)\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Defensive positioning amid macro uncertainty\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Emerging market volume growth in personal care\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Private label competition pressuring pricing\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"FX headwinds from strong USD on international revenues\",\"impact\":\"MED\",\"direction\":\"NEG\"}],\"risks\":[\"Continued revenue erosion if restructuring benefits do not materialize\",\"Debt burden limits strategic flexibility and raises refinancing risk\",\"Commodity input cost spikes compressing margins unexpectedly\",\"Consumer trade-down to private label accelerating in key categories\",\"Dividend sustainability questioned if FCF deteriorates\"],\"assumptions\":{\"revenue_cagr_3y\":0.02,\"ebit_margin_target\":0.155,\"wacc\":0.085,\"terminal_multiple\":14},\"scenarios\":{\"bear\":{\"target_price\":84,\"prob\":0.2,\"notes\":\"Earnings deteriorate further, multiple contracts to 16x forward on deleveraging concerns.\"},\"base\":{\"target_price\":112,\"prob\":0.55,\"notes\":\"Earnings stabilize near $5.50, forward PE re-rates to ~20x on restructuring progress.\"},\"bull\":{\"target_price\":128,\"prob\":0.25,\"notes\":\"Margin expansion and organic growth recovery drive EPS toward $6+, multiple expands.\"}},\"method_notes\":\"Blended valuation using forward PE (18-21x range on normalized EPS $5.20-6.00), EV/EBITDA (13-15x), and FCF yield (5-7% fair range). Stock's 33% decline from 52w high appears to overshoot fundamentals given solid FCF. High leverage and revenue decline cap conviction at moderate. 12M base target ~$112 implies ~15% upside supporting BUY. Not investment advice.\"}", "parsedJson": { "as_of": "2026-04-08T20:00:03.000Z", "model": "ai-equity-research-v1", "risks": [ "Continued revenue erosion if restructuring benefits do not materialize", "Debt burden limits strategic flexibility and raises refinancing risk", "Commodity input cost spikes compressing margins unexpectedly", "Consumer trade-down to private label accelerating in key categories", "Dividend sustainability questioned if FCF deteriorates" ], "ticker": "KMB", "currency": "USD", "scenarios": { "base": { "prob": 0.55, "notes": "Earnings stabilize near $5.50, forward PE re-rates to ~20x on restructuring progress.", "target_price": 112 }, "bear": { "prob": 0.2, "notes": "Earnings deteriorate further, multiple contracts to 16x forward on deleveraging concerns.", "target_price": 84 }, "bull": { "prob": 0.25, "notes": "Margin expansion and organic growth recovery drive EPS toward $6+, multiple expands.", "target_price": 128 } }, "confidence": 0.6, "assumptions": { "wacc": 0.085, "revenue_cagr_3y": 0.02, "terminal_multiple": 14, "ebit_margin_target": 0.155 }, "key_drivers": [ { "driver": "Revenue stabilization post-restructuring", "impact": "HIGH", "direction": "POS" }, { "driver": "FCF generation supporting dividend and deleveraging", "impact": "HIGH", "direction": "POS" }, { "driver": "Input cost deflation benefiting gross margins", "impact": "MED", "direction": "POS" }, { "driver": "Elevated leverage with D/E of 8.7x", "impact": "HIGH", "direction": "NEG" }, { "driver": "Weak liquidity ratios (current ratio 0.75)", "impact": "MED", "direction": "NEG" }, { "driver": "Defensive positioning amid macro uncertainty", "impact": "MED", "direction": "POS" }, { "driver": "Emerging market volume growth in personal care", "impact": "MED", "direction": "POS" }, { "driver": "Private label competition pressuring pricing", "impact": "MED", "direction": "NEG" }, { "driver": "FX headwinds from strong USD on international revenues", "impact": "MED", "direction": "NEG" } ], "method_notes": "Blended valuation using forward PE (18-21x range on normalized EPS $5.20-6.00), EV/EBITDA (13-15x), and FCF yield (5-7% fair range). Stock's 33% decline from 52w high appears to overshoot fundamentals given solid FCF. High leverage and revenue decline cap conviction at moderate. 12M base target ~$112 implies ~15% upside supporting BUY. Not investment advice.", "current_price": 97, "recommendation": "BUY", "thesis_bullets": [ "Stock trades near 52-week low with 33% drawdown from highs", "Forward PE of 18.8x implies market pricing partial earnings recovery", "Strong FCF yield of ~6.4% supports valuation floor and dividend", "Revenue and EPS declined ~18-20% YoY likely from divestitures or restructuring", "Defensive low-beta consumer staples name with 3.9% dividend yield" ], "target_price_6m": 104, "target_price_12m": 112 }, "errorsJson": { "attempts": [], "providerMeta": { "provider": "anthropic", "webSearch": { "enabled": false, "maxToolCalls": 2, "disabledReason": null }, "pauseTurns": 0, "stopReason": "end_turn" }, "sanityIssues": [] }, "latencyMs": 35865, "createdAt": "2026-04-09T05:21:14.755Z", "usage": { "inputTokens": 3649, "outputTokens": 1641, "costUsd": 0.05927 } }, { "id": "cmnr14du204pjp658dehvzg84", "runId": "cmnr14dtz04pep6588kf4ysob", "modelId": "deepseek.reasoner", "status": "SUCCESS", "rawOutput": "{\n \"model\": \"SeniorEquityResearchAnalyst\",\n \"as_of\": \"2026-04-08T20:00:03.000Z\",\n \"ticker\": \"KMB\",\n \"currency\": \"USD\",\n \"current_price\": 97,\n \"target_price_6m\": 98,\n \"target_price_12m\": 99,\n \"recommendation\": \"HOLD\",\n \"confidence\": 0.6,\n \"thesis_bullets\": [\n \"Established brands in essential consumer goods categories.\",\n \"Recent financial performance shows declining revenue and earnings.\",\n \"High leverage ratio increases risk during economic downturns.\",\n \"Dividend yield offers stable income for investors.\",\n \"Cost efficiency initiatives could improve margins over time.\"\n ],\n \"key_drivers\": [\n { \"driver\": \"Brand equity\", \"impact\": \"HIGH\", \"direction\": \"POS\" },\n { \"driver\": \"Revenue growth trends\", \"impact\": \"HIGH\", \"direction\": \"NEG\" },\n { \"driver\": \"Debt levels\", \"impact\": \"MED\", \"direction\": \"NEG\" },\n { \"driver\": \"Operational cost control\", \"impact\": \"MED\", \"direction\": \"POS\" },\n { \"driver\": \"Market competition\", \"impact\": \"MED\", \"direction\": \"NEG\" },\n { \"driver\": \"Economic conditions\", \"impact\": \"LOW\", \"direction\": \"NEG\" },\n { \"driver\": \"Product innovation\", \"impact\": \"LOW\", \"direction\": \"POS\" }\n ],\n \"risks\": [\n \"Further decline in sales volumes.\",\n \"Increased input costs pressuring margins.\",\n \"Difficulty in reducing high debt levels.\",\n \"Intensified competition from private labels.\"\n ],\n \"assumptions\": {\n \"revenue_cagr_3y\": 0.005,\n \"ebit_margin_target\": 0.15,\n \"wacc\": 0.075,\n \"terminal_multiple\": 12\n },\n \"scenarios\": {\n \"bear\": { \"target_price\": 85, \"prob\": 0.3, \"notes\": \"Continued decline in sales and margins.\" },\n \"base\": { \"target_price\": 99, \"prob\": 0.5, \"notes\": \"Stabilization with modest earnings recovery.\" },\n \"bull\": { \"target_price\": 110, \"prob\": 0.2, \"notes\": \"Successful cost cuts and market share gains.\" }\n },\n \"method_notes\": \"Valuation based on DCF with stated assumptions; target prices imply limited upside; not investment advice.\"\n}", "parsedJson": { "as_of": "2026-04-08T20:00:03.000Z", "model": "SeniorEquityResearchAnalyst", "risks": [ "Further decline in sales volumes.", "Increased input costs pressuring margins.", "Difficulty in reducing high debt levels.", "Intensified competition from private labels." ], "ticker": "KMB", "currency": "USD", "scenarios": { "base": { "prob": 0.5, "notes": "Stabilization with modest earnings recovery.", "target_price": 99 }, "bear": { "prob": 0.3, "notes": "Continued decline in sales and margins.", "target_price": 85 }, "bull": { "prob": 0.2, "notes": "Successful cost cuts and market share gains.", "target_price": 110 } }, "confidence": 0.6, "assumptions": { "wacc": 0.075, "revenue_cagr_3y": 0.005, "terminal_multiple": 12, "ebit_margin_target": 0.15 }, "key_drivers": [ { "driver": "Brand equity", "impact": "HIGH", "direction": "POS" }, { "driver": "Revenue growth trends", "impact": "HIGH", "direction": "NEG" }, { "driver": "Debt levels", "impact": "MED", "direction": "NEG" }, { "driver": "Operational cost control", "impact": "MED", "direction": "POS" }, { "driver": "Market competition", "impact": "MED", "direction": "NEG" }, { "driver": "Economic conditions", "impact": "LOW", "direction": "NEG" }, { "driver": "Product innovation", "impact": "LOW", "direction": "POS" } ], "method_notes": "Valuation based on DCF with stated assumptions; target prices imply limited upside; not investment advice.", "current_price": 97, "recommendation": "HOLD", "thesis_bullets": [ "Established brands in essential consumer goods categories.", "Recent financial performance shows declining revenue and earnings.", "High leverage ratio increases risk during economic downturns.", "Dividend yield offers stable income for investors.", "Cost efficiency initiatives could improve margins over time." ], "target_price_6m": 98, "target_price_12m": 99 }, "errorsJson": { "attempts": [], "providerMeta": { "endpoint": "https://api.deepseek.com/v1/chat/completions", "provider": "deepseek", "webSearch": { "enabled": false, "supported": false }, "responseFormat": "json_object" }, "sanityIssues": [] }, "latencyMs": 334, "createdAt": "2026-04-09T05:21:14.755Z", "usage": { "inputTokens": 2146, "outputTokens": 3456, "costUsd": 0.002052 } }, { "id": "cmnr14du204php658nsyydr4t", "runId": "cmnr14dtz04pep6588kf4ysob", "modelId": "gemini.3-pro", "status": "SUCCESS", "rawOutput": "{\n \"model\": \"Equity Research AI\",\n \"as_of\": \"2026-04-08T20:00:03.000Z\",\n \"ticker\": \"KMB\",\n \"currency\": \"USD\",\n \"current_price\": 97,\n \"target_price_6m\": 104,\n \"target_price_12m\": 110,\n \"recommendation\": \"BUY\",\n \"confidence\": 0.65,\n \"thesis_bullets\": [\n \"Defensive portfolio provides stability despite recent structural revenue adjustments.\",\n \"Margin expansion potential through aggressive cost-cutting and supply chain optimization.\",\n \"High 3.87% dividend yield provides significant total return support.\",\n \"Current valuation at 18.7x forward earnings is below historical 5-year averages.\",\n \"Market share stabilization in premium diaper categories supports long-term growth.\"\n ],\n \"key_drivers\": [\n {\n \"driver\": \"Pulp and energy input costs\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Consumer trade-down to private labels\",\n \"impact\": \"HIGH\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Restructuring program efficiency\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Emerging market volume recovery\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"US dollar strength impact\",\n \"impact\": \"LOW\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Debt refinancing costs\",\n \"impact\": \"MED\",\n \"direction\": \"NEG\"\n }\n ],\n \"risks\": [\n \"Persistent volume erosion in core North American markets.\",\n \"High leverage ratio increases sensitivity to interest rate volatility.\",\n \"Failure to pass through price increases to inflation-weary consumers.\"\n ],\n \"assumptions\": {\n \"revenue_cagr_3y\": 0.025,\n \"ebit_margin_target\": 0.165,\n \"wacc\": 0.072,\n \"terminal_multiple\": 15.0\n },\n \"scenarios\": {\n \"bear\": {\n \"target_price\": 85,\n \"prob\": 0.2,\n \"notes\": \"Recession leads to aggressive trade-down and volume loss.\"\n },\n \"base\": {\n \"target_price\": 110,\n \"prob\": 0.55,\n \"notes\": \"Successful margin recovery and stabilization of organic growth.\"\n },\n \"bull\": {\n \"target_price\": 125,\n \"prob\": 0.25,\n \"notes\": \"Significant pulp price deflation and rapid EM market share gains.\"\n }\n },\n \"method_notes\": \"Valuation utilizes a 19x forward P/E multiple on normalized EPS, supported by a 3.87% dividend yield. The BUY rating is predicated on margin recovery following recent revenue volatility noted in the snapshot. Not investment advice.\"\n}", "parsedJson": { "as_of": "2026-04-08T20:00:03.000Z", "model": "Equity Research AI", "risks": [ "Persistent volume erosion in core North American markets.", "High leverage ratio increases sensitivity to interest rate volatility.", "Failure to pass through price increases to inflation-weary consumers." ], "ticker": "KMB", "currency": "USD", "scenarios": { "base": { "prob": 0.55, "notes": "Successful margin recovery and stabilization of organic growth.", "target_price": 110 }, "bear": { "prob": 0.2, "notes": "Recession leads to aggressive trade-down and volume loss.", "target_price": 85 }, "bull": { "prob": 0.25, "notes": "Significant pulp price deflation and rapid EM market share gains.", "target_price": 125 } }, "confidence": 0.65, "assumptions": { "wacc": 0.072, "revenue_cagr_3y": 0.025, "terminal_multiple": 15, "ebit_margin_target": 0.165 }, "key_drivers": [ { "driver": "Pulp and energy input costs", "impact": "MED", "direction": "POS" }, { "driver": "Consumer trade-down to private labels", "impact": "HIGH", "direction": "NEG" }, { "driver": "Restructuring program efficiency", "impact": "HIGH", "direction": "POS" }, { "driver": "Emerging market volume recovery", "impact": "MED", "direction": "POS" }, { "driver": "US dollar strength impact", "impact": "LOW", "direction": "NEG" }, { "driver": "Debt refinancing costs", "impact": "MED", "direction": "NEG" } ], "method_notes": "Valuation utilizes a 19x forward P/E multiple on normalized EPS, supported by a 3.87% dividend yield. The BUY rating is predicated on margin recovery following recent revenue volatility noted in the snapshot. Not investment advice.", "current_price": 97, "recommendation": "BUY", "thesis_bullets": [ "Defensive portfolio provides stability despite recent structural revenue adjustments.", "Margin expansion potential through aggressive cost-cutting and supply chain optimization.", "High 3.87% dividend yield provides significant total return support.", "Current valuation at 18.7x forward earnings is below historical 5-year averages.", "Market share stabilization in premium diaper categories supports long-term growth." ], "target_price_6m": 104, "target_price_12m": 110 }, "errorsJson": { "attempts": [], "providerMeta": { "model": "gemini-3-flash-preview", "provider": "gemini", "webSearch": { "used": false, "allowed": false, "enabled": false, "requested": false, "disabledReason": null } }, "sanityIssues": [] }, "latencyMs": 16638, "createdAt": "2026-04-09T05:21:14.755Z", "usage": { "inputTokens": 2493, "outputTokens": 770, "costUsd": 0.014226 } }, { "id": "cmnr14du204pfp658yvcahc7o", "runId": "cmnr14dtz04pep6588kf4ysob", "modelId": "openai.gpt-5.4", "status": "SUCCESS", "rawOutput": "{\"model\":\"OpenAI o3\",\"as_of\":\"2026-04-08T20:00:03.000Z\",\"ticker\":\"KMB\",\"currency\":\"USD\",\"current_price\":97,\"target_price_6m\":100,\"target_price_12m\":102,\"recommendation\":\"HOLD\",\"confidence\":0.59,\"thesis_bullets\":[\"Staples brands support resilient cash flow and a 3.9% dividend yield.\",\"Forward P/E looks reasonable after the stock's sharp reset.\",\"Recent revenue and EPS declines show weak near-term demand and mix.\",\"High leverage and thin liquidity limit balance-sheet flexibility.\",\"Fair value sits near current price unless volumes recover faster.\"],\"key_drivers\":[{\"driver\":\"Pricing and mix retention\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Volume recovery in diapers and tissue\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Pulp and input cost normalization\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Productivity savings execution\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Promotional intensity/private label\",\"impact\":\"HIGH\",\"direction\":\"NEG\"},{\"driver\":\"FX and international demand\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Debt reduction and cash deployment\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Defensive rotation/dividend support\",\"impact\":\"LOW\",\"direction\":\"POS\"}],\"risks\":[\"Private-label share gains pressure volumes\",\"Commodity inflation outpaces pricing\",\"FX and emerging-market weakness\",\"Balance-sheet limits capital allocation\",\"Productivity program underdelivers\"],\"assumptions\":{\"revenue_cagr_3y\":0.02,\"ebit_margin_target\":0.155,\"wacc\":0.075,\"terminal_multiple\":12},\"scenarios\":{\"bear\":{\"target_price\":86,\"prob\":0.25,\"notes\":\"Volumes stay weak and margin recovery stalls.\"},\"base\":{\"target_price\":102,\"prob\":0.5,\"notes\":\"Modest growth and stable margins support limited rerating.\"},\"bull\":{\"target_price\":118,\"prob\":0.25,\"notes\":\"Volumes rebound and savings expand margins faster than expected.\"}},\"method_notes\":\"Base case blends ~18x forward earnings with normalized margin/FCF support, cross-checked to EV/EBIT and dividend yield. Snapshot quote/fundamentals were used as authoritative; no sell-side targets used. HOLD reflects modest upside offset by leverage and weak recent growth; not investment advice.\"}", "parsedJson": { "as_of": "2026-04-08T20:00:03.000Z", "model": "OpenAI o3", "risks": [ "Private-label share gains pressure volumes", "Commodity inflation outpaces pricing", "FX and emerging-market weakness", "Balance-sheet limits capital allocation", "Productivity program underdelivers" ], "ticker": "KMB", "currency": "USD", "scenarios": { "base": { "prob": 0.5, "notes": "Modest growth and stable margins support limited rerating.", "target_price": 102 }, "bear": { "prob": 0.25, "notes": "Volumes stay weak and margin recovery stalls.", "target_price": 86 }, "bull": { "prob": 0.25, "notes": "Volumes rebound and savings expand margins faster than expected.", "target_price": 118 } }, "confidence": 0.59, "assumptions": { "wacc": 0.075, "revenue_cagr_3y": 0.02, "terminal_multiple": 12, "ebit_margin_target": 0.155 }, "key_drivers": [ { "driver": "Pricing and mix retention", "impact": "HIGH", "direction": "POS" }, { "driver": "Volume recovery in diapers and tissue", "impact": "HIGH", "direction": "POS" }, { "driver": "Pulp and input cost normalization", "impact": "MED", "direction": "POS" }, { "driver": "Productivity savings execution", "impact": "MED", "direction": "POS" }, { "driver": "Promotional intensity/private label", "impact": "HIGH", "direction": "NEG" }, { "driver": "FX and international demand", "impact": "MED", "direction": "NEG" }, { "driver": "Debt reduction and cash deployment", "impact": "MED", "direction": "POS" }, { "driver": "Defensive rotation/dividend support", "impact": "LOW", "direction": "POS" } ], "method_notes": "Base case blends ~18x forward earnings with normalized margin/FCF support, cross-checked to EV/EBIT and dividend yield. Snapshot quote/fundamentals were used as authoritative; no sell-side targets used. HOLD reflects modest upside offset by leverage and weak recent growth; not investment advice.", "current_price": 97, "recommendation": "HOLD", "thesis_bullets": [ "Staples brands support resilient cash flow and a 3.9% dividend yield.", "Forward P/E looks reasonable after the stock's sharp reset.", "Recent revenue and EPS declines show weak near-term demand and mix.", "High leverage and thin liquidity limit balance-sheet flexibility.", "Fair value sits near current price unless volumes recover faster." ], "target_price_6m": 100, "target_price_12m": 102 }, "errorsJson": { "attempts": [], "providerMeta": { "provider": "openai", "webSearch": { "used": false, "enabled": false, "sources": [], "maxToolCalls": 2 }, "responseId": "resp_01dea2b51283a3da0069d75a9827348197b22ea8f30bea6616", "reasoningEffort": "medium", "structuredOutputs": { "used": true, "requested": true, "disabledReason": null } }, "sanityIssues": [] }, "latencyMs": 50521, "createdAt": "2026-04-09T05:21:14.755Z", "usage": { "inputTokens": 2411, "outputTokens": 2570, "costUsd": 0.040199 } }, { "id": "cmnr14du204pip658qw3jtl0i", "runId": "cmnr14dtz04pep6588kf4ysob", "modelId": "xai.grok-4.20-reasoning", "status": "SUCCESS", "rawOutput": "{\n \"model\": \"AI Model Recommendation\",\n \"as_of\": \"2026-04-08T20:00:03.000Z\",\n \"ticker\": \"KMB\",\n \"currency\": \"USD\",\n \"current_price\": 97,\n \"target_price_6m\": 105,\n \"target_price_12m\": 115,\n \"recommendation\": \"BUY\",\n \"confidence\": 0.62,\n \"thesis_bullets\": [\n \"Resilient demand for essential hygiene products supports stability.\",\n \"Recent revenue and EPS declines signal short-term challenges.\",\n \"Robust free cash flow sustains 3.9% dividend yield.\",\n \"Defensive low-beta profile attractive in volatile markets.\",\n \"Valuation near 52-week low offers reasonable entry point.\"\n ],\n \"key_drivers\": [\n {\n \"driver\": \"Essential product demand\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Raw material cost volatility\",\n \"impact\": \"HIGH\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Private label competition\",\n \"impact\": \"MED\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Pricing execution\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Innovation pipeline\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Emerging markets growth\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Balance sheet leverage\",\n \"impact\": \"MED\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Consumer spending trends\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n }\n ],\n \"risks\": [\n \"Prolonged volume declines in key categories\",\n \"Intensifying competition from private labels\",\n \"Significant input cost inflation\",\n \"Supply chain disruptions\",\n \"Foreign exchange headwinds\"\n ],\n \"assumptions\": {\n \"revenue_cagr_3y\": 0.03,\n \"ebit_margin_target\": 0.15,\n \"wacc\": 0.075,\n \"terminal_multiple\": 15\n },\n \"scenarios\": {\n \"bear\": {\n \"target_price\": 85,\n \"prob\": 0.3,\n \"notes\": \"Persistent volume weakness and margin erosion continue.\"\n },\n \"base\": {\n \"target_price\": 115,\n \"prob\": 0.5,\n \"notes\": \"Gradual recovery in sales and stable margins achieved.\"\n },\n \"bull\": {\n \"target_price\": 140,\n \"prob\": 0.2,\n \"notes\": \"Accelerated growth from innovation and cost discipline.\"\n }\n },\n \"method_notes\": \"DCF using 3% rev CAGR, 15% EBIT margin, 7.5% WACC, 15x terminal EV/EBITDA. Mixed growth but yield and valuation support BUY. Not investment advice.\"\n}", "parsedJson": { "as_of": "2026-04-08T20:00:03.000Z", "model": "AI Model Recommendation", "risks": [ "Prolonged volume declines in key categories", "Intensifying competition from private labels", "Significant input cost inflation", "Supply chain disruptions", "Foreign exchange headwinds" ], "ticker": "KMB", "currency": "USD", "scenarios": { "base": { "prob": 0.5, "notes": "Gradual recovery in sales and stable margins achieved.", "target_price": 115 }, "bear": { "prob": 0.3, "notes": "Persistent volume weakness and margin erosion continue.", "target_price": 85 }, "bull": { "prob": 0.2, "notes": "Accelerated growth from innovation and cost discipline.", "target_price": 140 } }, "confidence": 0.62, "assumptions": { "wacc": 0.075, "revenue_cagr_3y": 0.03, "terminal_multiple": 15, "ebit_margin_target": 0.15 }, "key_drivers": [ { "driver": "Essential product demand", "impact": "HIGH", "direction": "POS" }, { "driver": "Raw material cost volatility", "impact": "HIGH", "direction": "NEG" }, { "driver": "Private label competition", "impact": "MED", "direction": "NEG" }, { "driver": "Pricing execution", "impact": "MED", "direction": "POS" }, { "driver": "Innovation pipeline", "impact": "MED", "direction": "POS" }, { "driver": "Emerging markets growth", "impact": "MED", "direction": "POS" }, { "driver": "Balance sheet leverage", "impact": "MED", "direction": "NEG" }, { "driver": "Consumer spending trends", "impact": "MED", "direction": "POS" } ], "method_notes": "DCF using 3% rev CAGR, 15% EBIT margin, 7.5% WACC, 15x terminal EV/EBITDA. Mixed growth but yield and valuation support BUY. Not investment advice.", "current_price": 97, "recommendation": "BUY", "thesis_bullets": [ "Resilient demand for essential hygiene products supports stability.", "Recent revenue and EPS declines signal short-term challenges.", "Robust free cash flow sustains 3.9% dividend yield.", "Defensive low-beta profile attractive in volatile markets.", "Valuation near 52-week low offers reasonable entry point." ], "target_price_6m": 105, "target_price_12m": 115 }, "errorsJson": { "attempts": [], "providerMeta": { "provider": "xai", "webSearch": { "used": false, "enabled": false, "sources": [], "maxToolCalls": 2 }, "responseId": "5b04424d-1207-9fb7-a12b-f088dc71ee9c", "usedFallbackChatCompletions": false }, "sanityIssues": [] }, "latencyMs": 17303, "createdAt": "2026-04-09T05:21:14.755Z", "usage": { "inputTokens": 2751, "outputTokens": 3810, "costUsd": 0.065403 } } ] } }